March 13, 2017 / 8:44 PM / 5 months ago

BRIEF-Aratana Therapeutics posts Q4 loss per share $0.64

March 13 (Reuters) - Aratana Therapeutics Inc

* Aratana Therapeutics reports fourth quarter and full year 2016 financial results

* Q4 loss per share $0.64

* Q4 revenue $292,000

* Aratana Therapeutics Inc - expects cash, cash equivalents and short-term investments will fund operations and debt obligations through March 31, 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below